HRS-5685

N/A

Report date: 2025/02/28 13:58:29
NME

Base Information

Drug NameHRS-5685
Drug Alias NameHRS5685HRS7742
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Hengrui Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesRuikedi (Shanghai) biomedical Co Ltd
Inactive CompaniesRetrolead (HongKong) Biopharma Co Ltd
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A